To determine whether the anti-inflammatory effect of the PDE8 inhibitor contributed to the reversal of cognitive dysfunction and subsequent benefits for AD, we used 2 mouse models of AD, that is, AD mice generated by microinfusion of AβO into the hippocampus and APP/PS1 mice for behavioral tests. Here, APP is linked to Alzheimer disease.